LNA LNA Santé SA
LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeutic education for the patient and his/her family, geriatrics, enteral and parenteral nutrition, obstetrics, antenatal and postnatal, complex dressings and specific care, post-operative care, anti-cancer chemotherapy, post-chemotherapy, radiotherapy and aplasia monitoring, psychological or social care, neurological and orthopedic rehabilitation, palliative care, intensive nursing care, intravenous treatment/infusion, blood transfusion, education for the patient and his/her loved ones, paracentesis, pleural or peritoneal drainage, and other treatment services. In addition, the company offers general, ENT, carcinological, digestive and urology, dental, spinal, cosmetic, gynecological and obstetric, maxillo-facial, eye, ENT, orthopedic and trauma, plastic and cosmetic facial, stomatological, urological, vascular, and visceral and digestive surgery, as well as digestive endoscopies and hepato-gastroenterology services. Further, it provides follow-up care clinics or rehabilitation centers, centers for disabled and aging disabled persons, and personal services. LNA Santé SA was founded in 1990 and is based in Vertou, France.…
Industry Peers
Medical Care FacilitiesKey Statistics
About LNA Santé (EPA: LNA)
›
LNA Santé (EPA: LNA) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 8,777 employees.
The shares were at 25.30 EUR on 19 November 2026, up 9.5% over 52 weeks. Its 52-week range is 22.00 EUR to 36.50 EUR: the price is 30.7% below the high and 15.0% above the low.
At a market capitalisation of 260.49M EUR, it trades at 10.2 times trailing earnings and 7.7 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 57% for LNA. It pays a dividend yielding 3.63% (it pays out 26% of its earnings), against a median of 0.75% among the dividend payers in that peer group.
LNA Santé reports return on equity of 7.3%, an operating margin of 7.9% and revenue up 8.4% year over year.
Its debt exceeds its cash by 850.98M EUR, a debt-to-equity ratio of 2.74. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 41.10 EUR is 62.5% above the current price.